Carbamazepine-provoked hepatotoxicity and possible aetiopathological role of glutathione in the events: Retrospective review of old data and call for new investigation

作者: Miklós Péter Kalapos

DOI: 10.1007/BF03256188

关键词:

摘要: The antiepileptic drug (AED) carbamazepine is widely used in the treatment of different kinds seizures as well affective and behavioural disorders. This paper presents an epidemiological study carbamazepine-induced hepatic injuries death, describes possible mechanisms its toxicity. A retrospective analysis clinical data revealed that likelihood death was comparatively higher children, particularly when they were receiving medication with multiple AEDs, whereas reversible more likely to be seen elderly patients. As suggested this paper, development hepatotoxicity rare, unpredictable present state knowledge, but it somehow related disturbance glutathione metabolism, although regard are imperfect. There appear two types carbamazepine-initiated idiosyncratic liver injury, hypersensitivity toxin-induced. It feasible both due accumulation toxic metabolite(s), arene oxides may probably considered damaging derivatives metabolism. Despite lack clear-cut underlying experimental findings those patients whom inherited weakness eliminating capacity present, conditions deteriorate balance, increase possibility emergence events during therapy. Finally, some recommendations for therapy presented.

参考文章(115)
Luca Durelli, Umberto Massazza, Roberto Cavallo, Carbamazepine Toxicity and Poisoning Medical toxicology and adverse drug experience. ,vol. 4, pp. 95- 107 ,(1989) , 10.1007/BF03259906
EDY E. SOFFER, RICHARD J. TAYLOR, PHILLIP D. BERTRAM, RODGER C. HAGGITT, MICHAEL J. LEVINSON, Carbamazepine-induced liver injury. Southern Medical Journal. ,vol. 76, pp. 681- ,(1983) , 10.1097/00007611-198305000-00043
Yau Huei Wei, Hong Ming Wu, Chin San Liu, Shu Huei Kao, Serum trace elements, glutathione, copper/zinc superoxide dismutase, and lipid peroxidation in epileptic patients with phenytoin or carbamazepine monotherapy. Clinical Neuropharmacology. ,vol. 21, pp. 62- 64 ,(1998)
Charles D. Ponte, Carbamazepine-Induced Thrombocytopenia, Rash, and Hepatic Dysfunction Annals of Pharmacotherapy. ,vol. 17, pp. 642- 644 ,(1983) , 10.1177/106002808301700908
Sillanpää M, Carbamazepine. Pharmacology and clinical uses. Acta Neurologica Scandinavica. ,vol. 88, pp. 1- 202 ,(1981)
Andrejak M, Capron Jp, Davion T, Geoffroy P, Capron-Chivrac D, Quénum C, Acute hepatitis due to carbamazepine (Tegretol). Study of a case and review of the literature Gastroenterologie Clinique Et Biologique. ,vol. 8, pp. 52- 56 ,(1984)
Robert M Post, Thomas W Uhde, Peter P Roy-Byrne, Russell T Joffe, Antidepressant effects of carbamazepine. American Journal of Psychiatry. ,vol. 143, pp. 29- 34 ,(1986) , 10.1176/AJP.143.1.29
R. H. Levy, W. H. Pitlick, A. S. Troupin, J. R. Green, J. M. Neal, Pharmacokinetics of carbamazepine in normal man Clinical Pharmacology & Therapeutics. ,vol. 17, pp. 657- 668 ,(1975) , 10.1002/CPT1975176657
Gunnar Hopen, Ingerid Nesthus, Ole Didrik Laerum, Fatal Carbamazepine-Associated Hepatitis Acta Medica Scandinavica. ,vol. 210, pp. 333- 335 ,(2009) , 10.1111/J.0954-6820.1981.TB09826.X
A Meister, Glutathione metabolism and its selective modification. Journal of Biological Chemistry. ,vol. 263, pp. 17205- 17208 ,(1988) , 10.1016/S0021-9258(19)77815-6